*Cost-effectiveness study of the HEART score in the management of patients with chest pain presenting in the emergency room*

Completed

• Conditions: coronary artery disease; occlusion of the arteries of the heart; 10011082

• Registration Number: NL-OMON39519
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 6600

Inclusion Criteria

patient presenting with chest pain at the emergency room

Exclusion Criteria

Children (age <18 years)
Subjects who are (for whatever reason) not able to fill in questionnaires
STEMI (ST-elevation myocardial infarction)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>All patients will be followed for three months to assess the study outcome<br /><br>parameters.<br /><br>Primary outcome: occurrence of MACE (i.e. acute myocardial infarction (AMI),<br /><br>Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting<br /><br>(CABG) or death) within 6 weeks after presentation (non-inferiority approach). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>3 months incidence of MACE, quality of life and cost-effectiveness of the<br /><br>intervention compared with usual care. Furthermore, the number of missed events<br /><br>will be recorded. Also, we will be able to assess future biomarkers (like<br /><br>DNA-markers) in the extra bloodsample.<br /><br>furthermore, we will be able to assess possible women-specific risk factors by<br /><br>means of the women-specific questionnaire. </p><br>